DIH Holding US, Inc. (DHAI)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
DIH Holding US, Inc. (DHAI) trades at $0.02 with AI Score 48/100 (Grade C). DIH Holding US, Inc. is a robotics and virtual reality technology provider focused on the rehabilitation and human performance industry. Market cap: $41,853, Sector: Healthcare.
Price live · AI analysis from Mar 15, 2026Analyst Coverage for DHAI: DHAI does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates DHAI against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
DHAI: the 1 perspectives are evenly split.
How is this calculated? →DIH Holding US, Inc. (DHAI) Healthcare & Pipeline Overview
DIH Holding US, Inc. specializes in robotics and virtual reality solutions for rehabilitation and human performance. With a focus on medical devices, the company addresses the healthcare sector by providing technology-driven tools. DIH Holding operates with a negative profit margin and trades on the OTC market.
What Is the Investment Thesis for DHAI?
Investing in DIH Holding US, Inc. presents a high-risk, high-reward scenario given its current financial metrics and OTC market listing. The company's negative profit margin of -18.2% indicates operational challenges. However, its focus on robotics and virtual reality within the growing rehabilitation and human performance industry offers potential for future growth. Key value drivers include successful product innovation, strategic partnerships, and market penetration. Upcoming catalysts involve potential advancements in rehabilitation technology and expanded market reach. Investors should closely monitor the company's ability to improve profitability and navigate the complexities of the OTC market.
Based on FMP financials and quantitative analysis
DHAI Key Highlights
- DIH Holding US, Inc. operates in the robotics and virtual reality technology space within the rehabilitation and human performance industry.
- The company's market capitalization is $0.00B, indicating its small size within the healthcare sector.
- DIH Holding US, Inc. has a negative P/E ratio of -0.00, reflecting its current lack of profitability.
- The company's profit margin is -18.2%, suggesting operational inefficiencies or high costs.
- DIH Holding US, Inc. has a gross margin of 49.2%, indicating a reasonable ability to generate revenue from its products or services.
Who Are DHAI's Competitors?
DHAI is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| HSCS HeartSciences Inc. | $2.71 | -2.69% | $5.88M | — |
| DCTH Delcath Systems, Inc. | $13.61 | +3.11% | $469.84M | 73 |
| PYNKF Perimeter Medical Imaging AI, Inc. | $0.20 | +3.40% | $18.68M | 73 |
| SSII SS Innovations International, Inc. | $3.76 | -0.53% | $752.49M | 72 |
| RSHUF Respiri Limited | $0.06 | +0.00% | $91.52M | 68 |
| EW Edwards Lifesciences Corporation | $95.44 | +1.14% | $54.96B | 58 |
| PETV PetVivo Holdings, Inc. | $0.80 | -4.65% | $24.03M | 58 |
| AXGN AxoGen, Inc. | $45.08 | -1.77% | $2.40B | 58 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are DHAI's Key Strengths?
- Specialized in robotics and virtual reality for rehabilitation
- Proprietary technology and software
- Potential for growth in the expanding rehabilitation market
- Focus on improving patient outcomes
What Are DHAI's Weaknesses?
- Negative profit margin
- Small market capitalization
- Limited financial resources
- OTC market listing
What Could Drive DHAI Stock Higher?
- Potential advancements in rehabilitation technology.
- Strategic partnerships with hospitals and rehabilitation centers.
- Geographic expansion into new markets.
- Integration of AI and machine learning into rehabilitation programs.
- Development and marketing of tele-rehabilitation solutions.
What Are the Key Risks for DHAI?
- Financial-distress signal — its Altman Z-Score of -1.90 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Competition from larger medical device companies.
- Stringent regulatory requirements.
- Technological obsolescence.
- Economic downturn affecting healthcare spending.
- Limited financial disclosure due to OTC listing.
What Are the Growth Opportunities for DHAI?
- Expansion of Product Line: DIH Holding US, Inc. can expand its product line to include more diverse and specialized robotics and virtual reality solutions for rehabilitation. The market for advanced rehabilitation technologies is projected to reach $2.7 billion by 2028, offering a significant opportunity for growth. By investing in research and development, DIH Holding US, Inc. can create innovative products that address unmet needs in the rehabilitation market, attracting new customers and increasing revenue.
- Strategic Partnerships: Forming strategic partnerships with hospitals, rehabilitation centers, and sports training facilities can provide DIH Holding US, Inc. with access to new markets and customers. Collaborating with established healthcare providers can enhance the company's credibility and facilitate the adoption of its technologies. These partnerships can also lead to joint development projects, creating new revenue streams and expanding DIH Holding US, Inc.'s market reach. The timeline for establishing these partnerships is ongoing.
- Geographic Expansion: DIH Holding US, Inc. can expand its geographic presence by targeting new markets in Europe and Asia. The global rehabilitation market is experiencing rapid growth, particularly in developing countries with aging populations and increasing healthcare expenditures. By establishing a presence in these markets, DIH Holding US, Inc. can tap into new revenue streams and diversify its customer base. This expansion can be achieved through direct sales, distribution agreements, or joint ventures. Timeline for expansion is estimated within the next 3-5 years.
- Integration of AI and Machine Learning: Integrating artificial intelligence (AI) and machine learning (ML) into its robotics and virtual reality solutions can enhance the effectiveness and personalization of rehabilitation programs. AI and ML can be used to analyze patient data, optimize treatment plans, and provide real-time feedback to therapists. This integration can improve patient outcomes, reduce treatment costs, and differentiate DIH Holding US, Inc.'s products from competitors. The timeline for AI/ML integration is estimated within the next 2-3 years.
- Focus on Tele-rehabilitation: Developing and marketing tele-rehabilitation solutions can enable DIH Holding US, Inc. to reach a wider patient population and reduce the cost of rehabilitation services. Tele-rehabilitation involves using technology to deliver rehabilitation services remotely, allowing patients to receive treatment in the comfort of their own homes. This approach can improve access to care, reduce travel costs, and enhance patient convenience. The market for tele-rehabilitation is expected to grow significantly in the coming years, driven by advancements in technology and increasing demand for remote healthcare services. The timeline for tele-rehabilitation implementation is estimated within the next 1-2 years.
What Opportunities Does DHAI Have?
- Expansion of product line
- Strategic partnerships with healthcare providers
- Geographic expansion into new markets
- Integration of AI and machine learning
What Threats Does DHAI Face?
- Competition from larger medical device companies
- Stringent regulatory requirements
- Technological obsolescence
- Economic downturn affecting healthcare spending
What Are DHAI's Competitive Advantages?
- Specialized technology in robotics and virtual reality for rehabilitation.
- Proprietary software and algorithms for personalized therapy.
- Established relationships with healthcare providers.
What Does DHAI Do?
DIH Holding US, Inc., based in Norwell, Massachusetts, operates as a technology provider specializing in robotics and virtual reality for the rehabilitation and human performance industry. While the company's founding story remains undisclosed, its current operations focus on developing and marketing advanced technological solutions aimed at improving patient outcomes and enhancing human capabilities. The company's product and service offerings are centered around integrating robotics and virtual reality into rehabilitation programs and human performance enhancement strategies. These solutions are designed to assist healthcare professionals and individuals in achieving better results in therapy and training. DIH Holding US, Inc. caters to a niche market within the broader healthcare sector, focusing on technology-driven rehabilitation and performance enhancement. The company faces competition from other medical device and technology providers in this specialized area.
What Products and Services Does DHAI Offer?
- Develops robotics for rehabilitation.
- Creates virtual reality technology for human performance enhancement.
- Provides technology solutions to hospitals and rehabilitation centers.
- Offers products designed to improve patient outcomes.
- Focuses on integrating robotics and virtual reality into therapy programs.
- Aims to enhance human capabilities through technological advancements.
- Serves the healthcare sector with specialized medical devices.
How Does DHAI Make Money?
- Sells robotics and virtual reality equipment to healthcare providers.
- Generates revenue through service and maintenance contracts.
- Offers software and platform subscriptions for rehabilitation programs.
What Industry Does DHAI Operate In?
DIH Holding US, Inc. operates within the medical devices industry, a segment of the broader healthcare sector. This industry is characterized by technological innovation, stringent regulatory requirements, and increasing demand for advanced medical solutions. The rehabilitation and human performance market is experiencing growth, driven by an aging population, rising healthcare expenditures, and advancements in robotics and virtual reality technologies. DIH Holding US, Inc. competes with other medical device companies and technology providers, including BBLG, BDRX, GCTK, HSCS, and INM, all vying for market share in this evolving landscape.
Who Are DHAI's Key Customers?
- Hospitals and rehabilitation centers
- Sports training facilities
- Individual patients seeking rehabilitation services
Company Profile
DIH Holding US, Inc. operates in the Medical - Devices industry within the Healthcare sector. It is headquartered in Norwell, US. The company is led by CEO Lynden Bass. DHAI has traded publicly since 2024.
F-Score 3/9Financial Health
DIH Holding US, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -1.90 places it in the distress zone, a signal of elevated financial risk.
ROE 22%Key Financial Metrics
Return on equity for DIH Holding US, Inc. stands at 21.7%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -30.4%, showing how much profit it generates from its asset base. A current ratio of 0.49 means current liabilities exceed short-term assets, a liquidity point worth watching.
DHAI Valuation & Market Position
With a 42K market cap, DIH Holding US, Inc. sits in the micro-cap segment of the market. Relative to its peer group, DHAI's quantitative score of 48/100 is below the peer average of 71/100.
DHAI Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in DHAI's future, signaling potential undervaluation to some investors.
- The community buzz around DHAI indicates growing interest, possibly driven by positive news or speculation about upcoming catalysts.
- Some investors believe DHAI is well-positioned to capitalize on emerging market trends, leading to increased long-term growth.
- Positive narratives circulating within the community highlight DHAI's innovative approach, potentially attracting more attention and investment.
Bear Case
- Recent insider selling might indicate a lack of confidence in DHAI's short-term prospects among those with inside knowledge.
- Negative sentiment within the community suggests concerns about DHAI's current performance or future challenges.
- Some investors are worried about DHAI's ability to compete effectively in its industry, potentially hindering its growth.
- Bearish views within the community focus on DHAI's perceived weaknesses, raising doubts about its long-term viability.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · April 2026
DHAI Latest News
No recent news available for DHAI.
DHAI Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for DHAI.
Price Targets
Wall Street price target analysis for DHAI.
DHAI MoonshotScore
What does this score mean?
The MoonshotScore rates DHAI's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Lynden Bass
CEO
Lynden Bass serves as the CEO of DIH Holding US, Inc., overseeing the company's operations in the robotics and virtual reality technology sector for rehabilitation and human performance. Information regarding Mr. Bass's detailed career history, educational background, and previous roles is not available. As CEO, he is responsible for the strategic direction and overall performance of the company.
Track Record: As CEO of DIH Holding US, Inc., Lynden Bass manages a team of 178 employees. Specific achievements, strategic decisions, and company milestones under his leadership are not available. His focus is on guiding the company's growth and innovation in the rehabilitation technology market.
DHAI OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that DIH Holding US, Inc. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited operating history, lower trading volume, and may not be subject to the same level of regulatory scrutiny as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries significant risks due to the potential for fraud, lack of transparency, and limited liquidity.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure
- Low trading volume and liquidity
- Potential for price manipulation
- Higher risk of fraud or scams
- Limited regulatory oversight
- Verify the company's registration and legal status.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team's experience and track record.
- Understand the risks associated with investing in OTC stocks.
- Monitor trading volume and price volatility.
- Consult with a financial advisor.
- Company operates in a specific industry (rehabilitation robotics).
- Company has a CEO and employees.
- Company has a business address in Norwell, Massachusetts.
DHAI Healthcare Stock FAQ
What does DIH Holding US, Inc. do?
DIH Holding US, Inc. operates as a robotics and virtual reality technology provider in the rehabilitation and human performance industry. The company develops and markets advanced technological solutions aimed at improving patient outcomes and enhancing human capabilities. Its core business involves integrating robotics and virtual reality into rehabilitation programs and human performance enhancement strategies, serving healthcare professionals and individuals in achieving better results in therapy and training.
What do analysts say about DHAI stock?
Given that DIH Holding US, Inc. trades on the OTC market and has a small market capitalization, formal analyst coverage may be limited or non-existent. Investors should focus on the company's financial statements, business developments, and industry trends to form their own assessment. Key valuation metrics to consider include revenue growth, gross margin, and profitability. Growth considerations involve the company's ability to expand its product line, form strategic partnerships, and penetrate new markets.
What are the main risks for DHAI?
The main risks for DIH Holding US, Inc. include its negative profit margin, small market capitalization, and OTC market listing. The company faces competition from larger medical device companies and is subject to stringent regulatory requirements. Technological obsolescence and economic downturns affecting healthcare spending also pose potential risks. Additionally, the limited financial disclosure associated with OTC listings and potential price manipulation are significant concerns for investors.
What are the key factors to evaluate for DHAI?
DIH Holding US, Inc. (DHAI) holds an AI score of 48/100 (low). Not financial advice.
How frequently does DHAI data refresh on this page?
DHAI prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven DHAI's recent stock price performance?
DIH Holding US, Inc. (DHAI) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialized in robotics and virtual reality for rehabilitation. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider DHAI overvalued or undervalued right now?
Valuing DIH Holding US, Inc. (DHAI) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying DHAI?
Before investing in DIH Holding US, Inc. (DHAI), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is limited due to the company's OTC listing and disclosure status.
- Analyst coverage may be limited or non-existent.